Skip to main content
Premium Trial:

Request an Annual Quote

DOD Awards Pressure BioSciences $649K to Develop Pathogen Processing Platform

NEW YORK (GenomeWeb News) – Pressure BioSciences today announced the US Department of Defense has awarded it a $649,498 grant to develop a platform for processing pathogenic organisms.

The system to be developed under the Small Business Innovation Research Phase II grant will be based on Pressure Bio's pressure cycling technology. According to Richard Schumacher, president and CEO of the company, the grant covers "a substantial portion of the remaining development costs of an entirely new PCT-based instrument and consumables system … that we believe will fill an existing need for a fully automated high-throughput PCT-based system in the life sciences sample preparation market."

He estimated that market at $6 billion.

As part of the grant, Pressure Bio will work with scientists from the US Army Medical Research Institute of Infectious Diseases and the University of Texas Medical Branch to develop the system.

Last month, the company announced it received a $160,978 grant from the National Institutes of Health to develop a system for processing and preserving tissue samples.

It also has received several loans from investors as well as from Schumacher as the company tries to stay afloat. Last week, Pressure Bio was warned by Nasdaq of possible delisting because the company did not fulfill a requirement calling for at least $2.5 million in shareholders' equity. It also faces possible delisting for failure to meet a requirement of a minimum $1 bid price on its stock for at least 30 business days.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.